Diazepam Binding Inhibitor (DBI) Fragment (human) CAS 104360-70-5

Description

Compared with other compounds in its class, the molecular weight of 2150.37 g/mol gives Diazepam Binding Inhibitor (DBI) Fragment (human) distinctive chromatographic separation conditions and mass-spectrometry parameter settings.

Diazepam Binding Inhibitor (DBI) Fragment (human) (CAS 104360-70-5) is a high-purity analytical reference standard with the molecular formula C91H148N26O32S and a molecular weight of 2150.37 g/mol.

Structurally, Diazepam Binding Inhibitor (DBI) Fragment (human) (C91H148N26O32S) contains a nitrogen-containing heterocyclic scaffold, an amide group, a sulfone group, a hydroxyl group, an ether linkage. The molecule exhibits a degree of unsaturation (DBE) of 31.0, corresponding to approximately 31 ring(s) or double-bond equivalent(s). With a molecular weight of 2150.37 g/mol, it falls into the high-molecular-weight range. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).

This reference standard is suitable for quantitative analysis on major chromatographic platforms including HPLC, GC, LC-MS/MS, and GC-MS, serving as an external calibration standard or a system suitability test reference material.

As a certified reference material (CRM), Diazepam Binding Inhibitor (DBI) Fragment (human) meets the metrological traceability requirements of ISO/IEC 17025 laboratories. Batch-to-batch consistency is monitored via control charts to guarantee comparable assigned values across lots.

Physical & Chemical Properties

Why CATO?

• ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
• 130,000+ catalog items in stock, COA supplied with every batch
• Worldwide shipping with full export documentation (HS code guidance available)
• Technical support: +86 18665070610 / Nicole.chen@cato-chem.com